CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death

BACKGROUND: Patients diagnosed with triple negative breast cancer (TNBC) have limited treatment options and often suffer from resistance and toxicity due to chemotherapy. We previously found that depleting calcium and integrin-binding protein 1 (CIB1) induces cell death selectively in TNBC cells, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Alexander H., Leisner, Tina M., Dardis, Gabrielle J., Bivins, Marissa M., Keller, Alana L., Parise, Leslie V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360800/
https://www.ncbi.nlm.nih.gov/pubmed/30740034
http://dx.doi.org/10.1186/s12935-019-0740-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360800/
https://www.ncbi.nlm.nih.gov/pubmed/30740034
http://dx.doi.org/10.1186/s12935-019-0740-2

Ejemplares similares